精神分裂症患者全球功能评估中的最小临床重要差异 - Suppr

Suppr

超能文献

Minimum Clinically Important Difference in the Global Assessment Functioning in Patients with Schizophrenia.

作者信息

Amri I, Millier A, Toumi M

机构信息

Creativ-Ceutical, Tunis, Tunisia.

Creativ-Ceutical, Paris, France.

出版信息

Value Health. 2014 Nov;17(7):A765-6. doi: 10.1016/j.jval.2014.08.285. Epub 2014 Oct 26.

DOI:10.1016/j.jval.2014.08.285

PMID:27202809

Abstract

摘要

相似文献

Minimum Clinically Important Difference in the Global Assessment Functioning in Patients with Schizophrenia.精神分裂症患者全球功能评估中的最小临床重要差异

Value Health. 2014 Nov;17(7):A765-6. doi: 10.1016/j.jval.2014.08.285. Epub 2014 Oct 26.

Assessment of the minimum clinically important difference in quality of life in schizophrenia measured by the Quality of Well-Being Scale and disease-specific measures.采用健康状况调查问卷和疾病特异性量表评估精神分裂症患者生活质量的最小临床重要差异。

Psychiatry Res. 2013 Oct 30;209(3):291-6. doi: 10.1016/j.psychres.2013.01.016. Epub 2013 Mar 7.

Cognitive deficits and its relation with psychopathology and global functioning in first episode schizophrenia.首发精神分裂症认知缺陷及其与精神病理学和整体功能的关系。

Asian J Psychiatr. 2013 Dec;6(6):537-43. doi: 10.1016/j.ajp.2013.07.002. Epub 2013 Aug 13.

Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care.基于访谈的精神分裂症认知评估：精神分裂症认知评定量表（SCoRS）在疾病不同阶段和护理环境中的适用性。

Schizophr Res. 2013 May;146(1-3):217-23. doi: 10.1016/j.schres.2013.02.035. Epub 2013 Mar 17.

Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.评估认知疗法对低功能精神分裂症患者疗效的随机试验。

Arch Gen Psychiatry. 2012 Feb;69(2):121-7. doi: 10.1001/archgenpsychiatry.2011.129. Epub 2011 Oct 3.

Clinical symptoms and social functioning among immigrant and greek patients with schizophrenia: A comparative study.移民与希腊精神分裂症患者的临床症状及社会功能：一项对比研究。

Psychiatriki. 2009 Oct;20(4):319-28.

Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.失匹配负波缺陷与精神分裂症患者的功能不良有关。

Arch Gen Psychiatry. 2005 Feb;62(2):127-36. doi: 10.1001/archpsyc.62.2.127.

Personal and social functioning in schizophrenia: defining a clinically meaningful measure of maintenance in relapse prevention.精神分裂症患者的个人和社会功能：定义一种用于预防复发的维持治疗的有临床意义的衡量标准。

Curr Med Res Opin. 2010 Jun;26(6):1471-84. doi: 10.1185/03007991003798927.

Main determinants of Global Assessment of Functioning score in schizophrenia: a European multicenter study.精神分裂症中功能总体评定量表得分的主要决定因素：一项欧洲多中心研究

Compr Psychiatry. 2005 Nov-Dec;46(6):440-6. doi: 10.1016/j.comppsych.2005.03.006.

Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.用个人和社会表现量表测量处于精神分裂症急性期患者的社会功能：帕利哌酮缓释片三项 III 期临床试验汇总分析结果的解读。

Clin Ther. 2010 Feb;32(2):275-92. doi: 10.1016/j.clinthera.2010.02.003.

引用本文的文献

Effects of Spinal Cord Stimulation in Patients with Small Fiber and Associated Comorbidities from Neuropathy After Multiple Etiologies.脊髓刺激对多病因所致小纤维神经病变及相关合并症患者的影响

J Clin Med. 2025 Jan 20;14(2):652. doi: 10.3390/jcm14020652.

REWRITALIZE your recovery: a study protocol for a randomised controlled trial (RCT) examining the effectiveness of the new recovery-oriented creative writing group intervention REWRITALIZE for people with severe mental illness.“重焕生机”助力康复：一项随机对照试验（RCT）的研究方案，该试验旨在检验以康复为导向的新型创意写作小组干预措施“重焕生机”对重症精神疾病患者的有效性。

BMC Psychiatry. 2024 Dec 5;24(1):891. doi: 10.1186/s12888-024-06254-5.

Can atypical antipsychotics alleviate Deficits in psychosocial impairments in patients with a diagnosis of Borderline Personality? A systematic review and meta-analysis.非典型抗精神病药物能否缓解边缘型人格障碍患者的社会心理功能缺陷？一项系统评价和荟萃分析。

Psychiatry Res Commun. 2024 Sep;4(3):None. doi: 10.1016/j.psycom.2024.100187.

Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes.精神分裂症的临床结局评估工具：一项以患者报告结局的潜力为重点的范围性文献综述

Innov Clin Neurosci. 2023 Spring;20(4-6):14-33.

Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study).改善精神分裂症患者的功能：阿立哌唑一月一次（REACT 研究）的真实世界疗效。

BMC Psychiatry. 2023 May 31;23(1):383. doi: 10.1186/s12888-023-04893-8.

What Is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Analyses of a Phase III Clinical Trial.精神分裂症阴性症状的最小临床重要变化是什么？基于阳性和阴性症状量表（PANSS）对一项III期临床试验的分析。

Front Psychiatry. 2022 Apr 25;13:816339. doi: 10.3389/fpsyt.2022.816339. eCollection 2022.

Supervised treatment in outpatients for schizophrenia plus (STOPS+): protocol for a cluster randomised trial of a community-based intervention to improve treatment adherence and reduce the treatment gap for schizophrenia in Pakistan.门诊精神分裂症患者的监督治疗（STOPS+）：一项基于社区的干预措施改善治疗依从性和减少巴基斯坦精神分裂症治疗差距的群组随机试验方案。

BMJ Open. 2020 Jun 30;10(6):e034709. doi: 10.1136/bmjopen-2019-034709.

Psychological therapies for people with borderline personality disorder.针对边缘型人格障碍患者的心理治疗

Cochrane Database Syst Rev. 2020 May 4;5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2.

The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index.在德国进行的一项多中心、前瞻性、非对照、开放性队列研究中使用长效阿立哌唑：关于功能全面评估和世界卫生组织幸福指数的报告。

BMC Psychiatry. 2020 Feb 22;20(1):77. doi: 10.1186/s12888-020-02488-1.

Illness management and recovery: Clinical outcomes of a randomized clinical trial in community mental health centers.疾病管理和康复：社区心理健康中心的一项随机临床试验的临床结果。

PLoS One. 2018 Apr 5;13(4):e0194027. doi: 10.1371/journal.pone.0194027. eCollection 2018.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验